Stock Report

All about this stock under one free report Last Updated: 10-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Sierra Oncology (SRRA) Key Ratios

Stock Card factsheet share-fund-plan-icon

$54.99

$0.00 (0.00%)

As on 01-Jul-2022 09:30EDT

Market cap

info icon

$1,343 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

5.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -8.96 -40.70 -49.37 -41.10 -164.48
Net Profit -9.66 -40.24 -49.01 -49.62 -165.48
EPS 32.11 19.87 -10.31 20.34 13.15
Book Value -- -- -17.08 -46.13 -41.00
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-21Dec-20
EBIT-Margin info -26,920.00-26,920.00-----26,920.00
Net Margin info 41,288.9223,068.4295,955.14122,933.77521.31
Return on equity info -94.35-76.37-57.57-97.61-87.79
Return on Capital info -93.04-75.30---96.99-87.35
Return on Assets info -72.51-61.47-49.78-87.30-62.52
Debt to Equity (x) info ----0.020.010.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
-96.99
-87.35
-94.78
-54.96
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-57.57

Lower than Peers by 35.56

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
-57.57
-97.61
-87.79
-97.64
-56.38
Peer Median
-22.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-49.78

Lower than Peers by 37.23

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
-49.78
-87.30
-62.52
-67.70
-50.40
Peer Median
-12.55
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
--
-26,920.00
--
--
Peer Median
-50.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

95,955.14

Higher than Peers by 96,011.92

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
95,955.14
122,933.77
521.31
411.67
-2,996.35
Peer Median
-56.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
-1.00
--
--
--
Peer Median
16.10
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-49.37

Lower than Peers by 62.05

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
-49.37
-17.12
-75.31
16.87
-30.03
Peer Median
12.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-49.01

Lower than Peers by 57.39

Year on year growth in profit after tax

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
-49.01
-17.00
8.35
-65.51
-26.94
Peer Median
8.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-10.31

Lower than Peers by 41.56

Year on year growth in earnings per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
-10.31
0.01
0.75
-0.10
0.37
Peer Median
31.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

47.21

Higher than Peers by 45.07

Year on year growth in book value per share

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
47.21
--
--
--
--
Peer Median
2.14
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.02

--

Total debt / Net worth

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
0.02
0.01
0.00
0.01
0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
0.00
0.00
0.00
0.00
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

21.27

Higher than Peers by 17.55

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
21.27
8.34
11.38
2.32
10.77
Peer Median
3.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

21.27

Higher than Peers by 17.60

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
21.27
--
--
--
--
Peer Median
3.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
--
103.67
--
--
Peer Median
23.32
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
--
0.00
--
--
Peer Median
0.26
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
--
309.25
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
-2.99
-2.18
-0.01
-0.05
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

5.13

Higher than Peers by 0.24

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
5.13
2.94
1.80
0.01
0.03
Peer Median
4.90
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-10.50

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
-10.50
-1.90
-0.90
3.17
1.78
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

1,343

Higher than Peers by 1,252

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-21
Dec-20
Dec-19
Dec-18
Sierra Oncology (SRRA)
1,343
--
--
--
--
Peer Median
91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...